• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Anthem Changing Name to Elevance Health


The company also announced yesterday that will revive Wellpoint name in some markets.

Anthem announced yesterday that it is changing its name to Elevance Health and will revive the Wellpoint name in some markets.

The name change becomes official on June 28 and the company’s ticker symbol will be ELV. Elevance is blending of the words elevate and advance.

Healthcare services arm of the company, which is headquartered in Indianapolis, will be called Carelon.

The Anthem name will continue to be used with the company’s Anthem Blue Cross and Blue Shield and Anthem Blue Cross health plans.

The company adopted the Anthem in late 2014 after being known as Wellpoint.

“We are a different company today than were 10, five even three years ago,” said Gail K. Boudreaux, president and CEO in a video posted on the company’s website.Boudreaux said said the name changes were a major step in Anthem’s journey from a health benefits organization to a “lifetime trusted health partner.”

A Q&A on the website said the no leadership or organizational changes will occur with the name change.

The name change was unanimous support from by the company’s board of directors and was approved at a shareholder’s meeting on May 18,2022, according the Q&A.

Related Content
© 2024 MJH Life Sciences

All rights reserved.